Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study-Reference-Cited by-同舟云学术

Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study

Published:2022-03 Issue:3 Volume:9 Page:e208-e216
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Ranque Brigitte,Kitenge Robert,Ndiaye Dado Doucoure,Ba Mariama Dioulde,Adjoumani Leo,Traore Hélène,Coulibaly Catherine,Guindo Aldiouma,Boidy Kouakou,Mbuyi Didier,Ly Indou Deme,Offredo Lucile,Diallo Dapa Aly,Tolo Aissata,Kafando Eleonore,Tshilolo Leon,Diagne Ibrahima

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Sickle cell anemia: an underappreciated and unaddressed contributor to global childhood mortality;McGann;J Pediatr,2014

2. Sickle cell disease;Ware;Lancet,2017

3. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates;Piel;Lancet,2013

4. Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease;Lubeck;JAMA Netw Open,2019

5. Mortality rates and age at death from sickle cell disease: U.S., 1979–2005;Lanzkron;Public Health Rep,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sickle Cell Disease;Transfusion Medicine and Hemotherapy;2024-08-06

2. Evaluation of the Newborn Screening Pilot for Sickle Cell Disease in Suriname Using the Non-Adoption, Abandonment, Scale-Up, Spread, and Sustainability (NASSS) Framework;International Journal of Neonatal Screening;2024-07-04

3. Total Synthesis of a PSGL-1 Glycopeptide Analogue for Targeted Inhibition of P-Selectin;Journal of the American Chemical Society;2024-06-12

4. Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial;The Lancet Haematology;2024-06

5. Pronostic de la drépanocytose en Afrique : état des lieux et leviers d’action;Bulletin de l'Académie Nationale de Médecine;2024-05